The Current Landscape of Immune Checkpoint Inhibitor Immunotherapy for Primary and Metastatic Brain Tumors

Antibodies against immune checkpoint inhibitors (ICIs) have revolutionized the treatment of multiple aggressive malignancies, including melanoma and non-small cell lung cancer. ICIs for the treatment of primary and metastatic brain tumors have been used with varying degrees of success. Here, we disc...

Descripción completa

Detalles Bibliográficos
Autores principales: Alimonti, Paolo, Gonzalez Castro, L. Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123751/
https://www.ncbi.nlm.nih.gov/pubmed/37092448
http://dx.doi.org/10.3390/antib12020027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123751/
https://www.ncbi.nlm.nih.gov/pubmed/37092448
http://dx.doi.org/10.3390/antib12020027

Ejemplares similares